News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Court Overturns Fresenius Medical Care's $83 Million Medicare Fraud Loss


10/12/2012 9:05:01 AM

A federal appeals court says there was no evidence that Fresenius submitted false claims to Medicare, overturning a $82.6 million whistleblower suit brought by former employees. The U.S. 6th Circuit Court of Appeals dismissed a $82.6 million judgment against Fresenius (NYSE:FMS) Medical Care Holdings, finding that the company did not violate Medicare's rules concerning dialysis claims. Renal Care Group, which was acquired by German-owned Fresenius in 2005, was accused of improperly billing the Medicare program for home dialysis supplies and equipment between 1999 and 2005 and was ordered to pay $82.6 million in damages. In 2010 Fresenius appealed that decision and said Renal Care Group had done nothing wrong. Last Friday, a 3-judge panel reversed a lower court's ruling againt the medical device maker, and Judge Guy Cook wrote that Fresenius did not act with "reckless disregard of legal mandates."

Read at MassDevice
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES